Currently out of the existing stock ratings of Michael Yee, 219 are a BUY (78.49%), 60 are a HOLD (21.51%).

Michael Yee

Work Performance Price Targets & Ratings Chart

Analyst Michael Yee works at JEFFERIES with a stock forecast success ratio of 56.23% fulfilled within 186.82 days on average.

Michael Yee’s has documented 552 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Industrials, Pharmaceuticals sectors.

Most recent stock forecast was given on NUVB, Nuvation Bio at 27-Mar-2024.

Wall Street Analyst Michael Yee

Analyst best performing recommendations are on KOD (KODIAK SCIENCES).
The best stock recommendation documented was for KOD (KODIAK SCIENCES) at 7/24/2023. The price target of $3 was fulfilled within 3 days with a profit of $0.95 (24.05%) receiving and performance score of 80.17.

Average potential price target upside

of $155.6 (65.76%) on ASMB (ASSEMBLY BIOSCIENCES).
of $58.89 (30.85%) on AMGN (AMGEN).
of $38 (19.55%) on VRTX (VERTEX PHARMACEUTICALS).

ACOR Acorda Therapeutics ADGI Adagio Therapeutics ALGS Aligos Therapeutics AMRN Amarin PLC ASMB Assembly Biosciences EPZM Epizyme ESPR Esperion Therapeutics GILD Gilead Sciences ICPT Intercept Pharmaceuticals MRNA Moderna PRTA Prothena plc SDGR Schrodinger AMGN Amgen VRTX Vertex Pharmaceuticals AXON Axon Enterprise . BIIB Biogen BMRN Biomarin Pharmaceutical CELG Celgene CERE Cerevel Therapeutics Holdings FGEN FibroGen ONCE Spark Therapeutics ODT Odonate Therapeutics ZLAB Zai Lab Ltd SRRK Scholar Rock Holding Corp VTYX Ventyx Biosciences NUVB Nuvation Bio IMCR Immunocore Holdings Ltd LIAN LianBio ADR ALLO Allogene Therapeutics KOD Kodiak Sciences ALXO Alx Oncology Holdings BEAM Beam Therapeutics RXDX Prometheus Biosciences

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Raghuram Selvaraju (HC WAINWRIGHT)